Protein family
Protein sequence
Protein function
Catalytic activity
EC number
EC number description
1.14.11.-
Oxidoreductases;
Acting on paired donors, with incorporation or reduction of molecular oxygen;
With 2-oxoglutarate as one donor, and incorporation of one atom of oxygen into each donor;
1.14.11.53
Oxidoreductases;
Acting on paired donors, with incorporation or reduction of molecular oxygen;
With 2-oxoglutarate as one donor, and incorporation of one atom of oxygen into each donor;
mRNA N6-methyladenine demethylase
PDB | Resolution (Å) | PDB name |
---|---|---|
3LFM | 2.5 | Crystal structure of the fat mass and obesity associated (FTO) protein reveals basis for its substrate specificity |
4CXW | 3.1 | Crystal structure of human FTO in complex with subfamily-selective inhibitor 12 |
4CXX | 2.76 | Crystal structure of human FTO in complex with acylhydrazine inhibitor 16 |
4CXY | 2.65 | Crystal structure of human FTO in complex with acylhydrazine inhibitor 21 |
4IDZ | 2.46 | Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with N-oxalylglycine (NOG) |
4IE0 | 2.53 | Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with pyridine-2,4-dicarboxylate (2,4-PDCA) |
4IE4 | 2.5048 | Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with 5-carboxy-8-hydroxyquinoline (IOX1) |
4IE5 | 1.95 | Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with N-[(3-hydroxypyridin-2-yl)carbonyl]glycine (MD6) |
4IE6 | 2.5036 | Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with N-[(1-chloro-4-hydroxyisoquinolin-3-yl)carbonyl]glycine (IOX3/UN9) |
4IE7 | 2.6004 | Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with citrate and rhein (RHN) |
4QHO | 2.37 | Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with CCO10 |
4QKN | 2.2 | Crystal structure of FTO bound to a selective inhibitor |
4ZS2 | 2.16 | Structural complex of FTO/fluorescein |
4ZS3 | 2.45 | Structural complex of 5-aminofluorescein bound to the FTO protein |
5DAB | 2.1 | Crystal structure of FTO-IN115 |
5F8P | 2.2 | A Novel Inhibitor of the Obesity-Related Protein FTO |
5ZMD | 3.3 | Crystal structure of FTO in complex with m6dA modified ssDNA |
6AEJ | 2.8 | Crystal structure of human FTO in complex with small-molecule inhibitors |
6AK4 | 2.8 | Crystal structure of human FTO in complex with small-molecule inhibitors |
6AKW | 2.2 | Crystal structure of RNA dioxygenase bound with an inhibitor |
7CKK | 2.35 | Structural complex of FTO bound with Dac51 |
7E8Z | 2.55 | Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with SS81 |
7WCV | 2.3 | Co-crystal structure of FTO bound to 6e |
GO ontology | GO term | GO description |
---|---|---|
Biological Process | GO:0006307 | DNA dealkylation involved in DNA repair |
Biological Process | GO:0080111 | DNA demethylation |
Biological Process | GO:0042245 | RNA repair |
Biological Process | GO:0060612 | adipose tissue development |
Biological Process | GO:0061157 | mRNA destabilization |
Biological Process | GO:0070989 | oxidative demethylation |
Biological Process | GO:0035552 | oxidative single-stranded DNA demethylation |
Biological Process | GO:0035553 | oxidative single-stranded RNA demethylation |
Biological Process | GO:0090335 | regulation of brown fat cell differentiation |
Biological Process | GO:0010883 | regulation of lipid storage |
Biological Process | GO:0040014 | regulation of multicellular organism growth |
Biological Process | GO:0044065 | regulation of respiratory system process |
Biological Process | GO:0070350 | regulation of white fat cell proliferation |
Biological Process | GO:0001659 | temperature homeostasis |
Molecular Function | GO:0043734 | DNA-N1-methyladenine dioxygenase activity |
Molecular Function | GO:0008198 | ferrous iron binding |
Molecular Function | GO:1990931 | mRNA N6-methyladenosine dioxygenase activity |
Molecular Function | GO:0035516 | oxidative DNA demethylase activity |
Molecular Function | GO:0035515 | oxidative RNA demethylase activity |
Molecular Function | GO:1990984 | tRNA demethylase activity |
Molecular Function | GO:0016740 | transferase activity |
Cellular Component | GO:0005737 | cytoplasm |
Cellular Component | GO:0005829 | cytosol |
Cellular Component | GO:0043231 | intracellular membrane-bounded organelle |
Cellular Component | GO:0016607 | nuclear speck |
Cellular Component | GO:0005654 | nucleoplasm |
Cellular Component | GO:0005634 | nucleus |
Cellular Component | GO:0005886 | plasma membrane |
InterPro | InterPro name |
---|---|
IPR024366 | Alpha-ketoglutarate-dependent dioxygenase FTO, C-terminal |
IPR024367 | Alpha-ketoglutarate-dependent dioxygenase FTO, catalytic domain |
IPR032868 | Alpha-ketoglutarate-dependent dioxygenase FTO |
IPR037151 | Alpha-ketoglutarate-dependent dioxygenase AlkB-like superfamily |
IPR038413 | FTO, C-terminal domain superfamily |
Pfam | Pfam name |
---|---|
PF12933 | FTO catalytic domain |
PF12934 | FTO C-terminal domain |
Reactome | Reactome Name | Node type | Reactome Root | Reactome Root Name |
---|---|---|---|---|
R-HSA-73943 | Reversal of alkylation damage by DNA dioxygenases | Internal node | R-HSA-73894 | DNA Repair |
Location | ECO term | Pubmed |
---|---|---|
Cytoplasm | ECO:0000269 | PubMed:30197295 |
Nucleus | ECO:0000269 | PubMed:22002720 |
Nucleus | ECO:0000269 | PubMed:26458103 |
Nucleus | ECO:0000269 | PubMed:28002401 |
Nucleus | ECO:0000269 | PubMed:30197295 |
Nucleus speckle | ECO:0000269 | PubMed:22002720 |
HPO ID | HPO name |
---|---|
HP:0000007 | Autosomal recessive inheritance |
HP:0000028 | Cryptorchidism |
HP:0000175 | Cleft palate |
HP:0000193 | Bifid uvula |
HP:0000233 | Thin vermilion border |
HP:0000238 | Hydrocephalus |
HP:0000278 | Retrognathia |
HP:0000280 | Coarse facial features |
HP:0000407 | Sensorineural hearing impairment |
HP:0000463 | Anteverted nares |
HP:0000470 | Short neck |
HP:0000965 | Cutis marmorata |
HP:0001156 | Brachydactyly |
HP:0001250 | Seizure |
HP:0001276 | Hypertonia |
HP:0001305 | Dandy-Walker malformation |
HP:0001339 | Lissencephaly |
HP:0001508 | Failure to thrive |
HP:0001511 | Intrauterine growth retardation |
HP:0001537 | Umbilical hernia |
HP:0001612 | Weak cry |
HP:0001629 | Ventricular septal defect |
HP:0001639 | Hypertrophic cardiomyopathy |
HP:0001643 | Patent ductus arteriosus |
HP:0001800 | Hypoplastic toenails |
HP:0002678 | Skull asymmetry |
HP:0003577 | Congenital onset |
HP:0003819 | Death in childhood |
HP:0005484 | Secondary microcephaly |
HP:0006129 | Drumstick terminal phalanges |
HP:0009085 | Alveolar ridge overgrowth |
HP:0010808 | Protruding tongue |
HP:0011344 | Severe global developmental delay |
HP:0011461 | Fetal onset |
HP:0012444 | Brain atrophy |
Disease name | MONDO ID | ICD10 | ICD10 chapter | OMIM | Orphanet |
---|---|---|---|---|---|
lethal polymalformative syndrome, boissel type | MONDO:0013050 | Q87 | chapter17, Congenital malformations, deformations and chromosomal abnormalities | OMIM:612938 | Orphanet:210144 |
inherited obesity | MONDO:0019182 | E66 | chapter4, Endocrine, nutritional and metabolic diseases | OMIM:601665 | Orphanet:77828 |